Home Situations EVT.DE — Profile and price weak
Situation · 2026-07-03

EVT.DE — Profile and price weak

Discount Persists Amid Deep Capital Strain

Updated 2026-07-03 · Ref: Healthcare
Key metrics — 2026-07-03
Peer score
16
Quality pct
9
Valuation pct
30
52w drawdown
-31.1%
21d vs sector
-15.2%
Peer group
Healthcare
Situation summary

Evotec’s strong 14.5% revenue growth and guidance delivery contrast with persistently negative ROIC and net income. Operational momentum is intact, but deep losses and extreme volatility keep risk high. The main stress lies in capital returns and financial stability. A rerating would require clear improvement in ROIC, net income, and risk profile.

Published by AssetNext · 2026-04-15

All companies with this signal today

View full list: Profile and price weak →

Related pages for EVT.DE
Full peer analysis for Evotec SE →Similar companies to EVT.DEEVT.DE peersAll EVT.DE comparisonsHDAX context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-06-26 Profile and price weak 16 -34.2% -13.7%
2026-06-19 Profile and price weak 16 -37.9% -10.9%

See EVT.DE's full peer analysis

Break down EVT.DE's structural position across all peer dimensions with the interactive app.

Open EVT.DE in AssetNext →